Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 1;96(5):534-537.
doi: 10.1002/ajh.26132. Epub 2021 Mar 9.

Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination

Eun-Ju Lee  1 , Douglas B Cines  2 , Terry Gernsheimer  3 , Craig Kessler  4 , Marc Michel  5 , Michael D Tarantino  6 , John W Semple  7 , Donald M Arnold  8 , Bertrand Godeau  5 , Michele P Lambert  9   10 , James B Bussel  11
Affiliations

Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination

Eun-Ju Lee et al. Am J Hematol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

E.L., and J.W.S. declare no conflict of interest. D.B.C. has received relevant research support from Alexion and Aplagon, and served as a consultant to Rigel, Dova, and CSL Behring. T.G. has received honoraria from Amgen; has acted as a consultant for Amgen, Dova Pharmaceuticals, Biogen, Cellphire, Fujifilm, Rigel, Shionogi, and Principia; and has received research support from Principia. C.K. has served on advisory boards for Novartis, Rigel, Dova, Pfizer. M.M. has received research support from GSK, and received fees from LFB. M.D.T. has received research funding from Grifols and Novo Nordisk; is on advisory boards for Biogen, Grifols, Kedrion, Novo Nordisk, Pfizer, and Takeda; is a speaker for Amgen, Grifols, Octapharma, and Takeda; and reviews grants for Pfizer. D.M.A. has received research funding from Novartis, Bristol‐Myers Squibb, and Rigel and has acted as a consultant for Novartis, Principia, and Rigel. B.G. served as an expert for Amgen, Novartis, LFB and Roche; has received research support from Amgen and Roche. M.P.L. has served on advisory boards for Octapharma and Shionogi, has acted as a consultant for Amgen, Novartis, Shionogi, Dova, Principia, Argenx, Rigel and Bayer, and has received research funding from Sysmex, Novartis, Rigel and Astra Zeneca. J.B.B. has served on advisory boards and/or consulted for Amgen, Novartis, Dova, Rigel, UCB, Argenx, Momenta, Regeneron, RallyBio, and CSL‐Behring.

References

    1. Weintraub K. Death of Florida doctor after receiving COVID‐19 vaccine under investigation. USA Today. Published January 6, 2021. https://www.usatoday.com/story/news/health/2021/01/06/death-florida-doct....
    1. Grady D, Mazzei P. Doctor's death after Covid vaccine is being investigated. The New York Times. Published January 12, 2021. https://www.nytimes.com/2021/01/12/health/covid-vaccine-death.html.
    1. Tarawneh OH, Tarawneh HS. Immune thrombocytopenia in a 22‐year‐old post Covid‐19 vaccine. Am J Hematol. 2021;96:E133–E181. - PMC - PubMed
    1. Toom SWB, Avula A, Peeke S, Becker K. Familial thrombocytopenia flare‐up following the first dose of mRA‐1273 COVID‐19 vaccine. Am J Hematol. 2021. 10.1002/ajh.26128. [Epub ahead of print]. - DOI - PMC - PubMed
    1. Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA‐1273 SARS‐CoV‐2 vaccine. N Engl J Med. 2021;384:403‐416. - PMC - PubMed

MeSH terms